Home | Technology News Search Engine:
|
|
|
Home: Technology News:
|
|
(IT-NEWSWIRE.COM, May 24, 2018 ) The virus like particle based vaccines is commercially available in market against the hepatitis B virus and human papillomavirus. The viruses like particle based vaccines against several other viruses are in clinical development. The under trial vaccine candidates itself represents the target antigen and those in which the virus like particle is used to present the foreign antigens to immune system.
FREE | Request sample copy @ http://www.reportsweb.com/inquiry&RW00011942578/sample
Key manufacturers are included based on manufacturing sites, capacity and production, product specifications etc.: GlaxoSmithKline, Merck, Novavax, Takeda, Medicago, MedImmune, MedImmune, Agilvax, Allergy Therapeutics, Serum Institute of India, GeoVax Labs, Cytos Biotechnology, ANGANY Genetics, CPL Biologicals, Xiamen Innovax Biotech
Major applications as follows: Vaccines Mycoviruses Virus Research Therapeutic and Imaging Agents
Major Type as follows: Adeno-Associated Virus HIV Hepatitis B Virus Hepatitis C Virus
Regional market size, production data and export & import: Asia-Pacific North America Europe South America Middle East & Africa
Have any query? Enquire about report @ http://www.reportsweb.com/inquiry&RW00011942578/buying
Fundamentals of Table of Content:
1 Global Market Overview 1.1 Scope of Statistics 1.1.1 Scope of Products 1.1.2 Scope of Manufacturers 1.1.3 Scope of Application 1.1.4 Scope of Regions/Countries 1.2 Global Market Size
2 Regional Market 2.1 Regional Production 2.2 Regional Demand 2.3 Regional Trade
3 Key Manufacturers
4 Major Application
5 Market Price
6 Conclusion
Get more information @ http://www.reportsweb.com/global-virus-like-particles-market-data-survey-report-2025
ReportsWeb.com
Rajat Sahni
+1-646-491-9876
sales@reportsweb.com
Source: EmailWire.Com
Source: EmailWire.com
|
|
|
|
Technology News Headlines
|
|
|
Technology Business Video Feed
|
More Technology Video Feeds
|
|
|